The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples